Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas
BackgroundGliomas are common aggressive brain tumors with poor prognosis. Dephosphorylation-related biomarkers are in a void in gliomas. This study aims to construct a validated prognostic risk model for dephosphorylation, which will provide new directions for clinical treatment, prognostic assessme...
Saved in:
Main Authors: | Hui Tang, Xuping Yang, Guoqian Li, Ke Peng, Yang Sun, Longyang Jiang, Yilan Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1488894/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy
by: Gu W, et al.
Published: (2025-01-01) -
Identification of critical biomarkers and immune landscape patterns in glioma based on multi-database
by: Hanzhang Yuan, et al.
Published: (2025-01-01) -
LAMB1 downregulation suppresses glioma progression by inhibiting aerobic glycolysis through regulation of the NF-κB/HK2 axis
by: Zhenxiang Zhao, et al.
Published: (2025-02-01) -
RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
by: Wei Wei, et al.
Published: (2025-01-01) -
CircRNAs as Possible Potential Biomarkers for Breast Cancer Prognosis and Chemotherapy Response: A Comprehensive Study
by: Saba Mirzaei, et al.
Published: (2024-10-01)